Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Activating transcription factor 7 interacting protein 2 pseudogene (ENSG00000254957) is a nonfunctional genomic DNA sequence that resembles the functional ATF7IP2 gene but lacks the ability to produce a functional protein due to disruptive mutations or absence of necessary regulatory elements[2][5][8]. Pseudogenes arise through gene duplication or retrotransposition, followed by mutation; they are generally considered genomic fossils and do not have canonical biological function, nor are they therapeutic drug targets[2][4][6]. There is no current evidence that this particular pseudogene is transcribed or regulates other genes. This entry is distinct from the true protein-coding gene "Activating transcription factor 7 interacting protein 2" (ATF7IP2, ENSG00000166669), which is involved in transcriptional regulation and chromatin modification[1]. The pseudogene does not encode a protein, is not a drug target, and should not be confused with the true ATF7IP2 locus.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Activating transcription factor 7 interacting protein 2 pseudogene (null).